The role of opioid receptor phosphorylation and trafficking in adaptations to persistent opioid treatment

Emma E. Johnson, MacDonald J. Christie, Mark Connor*

*Corresponding author for this work

Research output: Contribution to journalReview article

38 Citations (Scopus)

Abstract

μ-Opioid receptor activation underpins clinical analgesia and is the central event in the abuse of narcotics. Continued opioid use produces tolerance to the acute effects of the drug and adaptations that lead to physical and psychological dependence. Continued μ-receptor signaling provides the engine for these adaptations, with most evidence suggesting that chronic agonist treatment produces only limited alterations in primary μ-opioid receptor signaling. Here we examine agonist regulation of μ-opioid receptor function, and whether this is altered by chronic treatment. Receptor phosphorylation is thought to be the key initial event in agonist regulation of the μ-opioid receptor, providing a signal for acute receptor desensitization and also subsequent receptor resensitization. Morphine appears to produce qualitatively and quantitatively different μ-receptor phosphorylation than other agonists, but the consequences of this remain obscure, at least in neurons. There is no evidence that agonist-induced μ-opioid receptor phosphorylation changes in chronically morphine-treated animals, although receptor regulation appears to be altered. Thus, as receptor phosphorylation and resensitization appear to maintain continued signaling through the μ-opioid receptor, these two events are crucial in facilitating adaptations to chronic opioid treatment, and the possibility that agonist-specific phosphorylation can contribute to the development of different adaptations remains open.

Original languageEnglish
Pages (from-to)290-302
Number of pages13
JournalNeuroSignals
Volume14
Issue number6
DOIs
Publication statusPublished - Jun 2006
Externally publishedYes

Fingerprint Dive into the research topics of 'The role of opioid receptor phosphorylation and trafficking in adaptations to persistent opioid treatment'. Together they form a unique fingerprint.

  • Cite this